MAPK/ERK signaling pathway in hepatocellular carcinoma

H Moon, SW Ro - Cancers, 2021 - mdpi.com
Simple Summary The mitogen-activated protein kinase/extracellular signal-regulated kinase
(MAPK/ERK) signaling pathway is frequently activated in liver cancer, which is one of the …

The Ras/Raf/MEK/ERK signaling pathway and its role in the occurrence and development of HCC

L Li, GD Zhao, Z Shi, LL Qi, LY Zhou… - Oncology …, 2016 - spandidos-publications.com
Hepatocellular carcinoma (HCC) is the fifth most common tumor worldwide and has a very
poor prognosis. Its occurrence has been on the increase in recent years. Surgical resection …

Activation of mitogen-activated protein kinases/extracellular signal-regulated kinases in human hepatocellular carcinoma

Y Ito, Y Sasaki, M Horimoto, S Wada, Y Tanaka… - Hepatology, 1998 - journals.lww.com
Mitogen-activated protein kinase/extracellular signal-regulated protein kinase (MAPK/ERK)
is a key molecule in intracellular signal transducing pathways that transport extracellular …

Targeting the Ras/Raf/MEK/ERK pathway in hepatocellular carcinoma

S Yang, G Liu - Oncology letters, 2017 - spandidos-publications.com
Although the biological basis of hepatocellular carcinoma (HCC) remains unclear, effective
treatments and improvement of the survival rate remain worthwhile research goals …

Mitogen-activated protein kinases in hepatocellular carcinoma development

L Min, B He, L Hui - Seminars in cancer biology, 2011 - Elsevier
Hepatocellular carcinoma (HCC) is among the most frequently occurring cancers and the
leading causes of cancer mortality worldwide. Identification of the signaling pathways …

Multiple anticancer effects of blocking MEK-ERK signaling in hepatocellular carcinoma1

CA Wiesenauer, MT Yip-Schneider… - Journal of the …, 2004 - journals.lww.com
Background Human hepatocellular carcinoma (HCC) is associated with increased
expression and activity of mitogen-activated protein kinase (MAPK) signaling intermediates …

The Ras/MAPK pathway and hepatocarcinoma: pathogenesis and therapeutic implications

B Delire, P Stärkel - European journal of clinical investigation, 2015 - Wiley Online Library
Background Hepatocellular carcinoma (HCC) is still a major health problem, often
diagnosed at an advanced stage. The multikinase inhibitor sorafenib is to date the sole …

Over-expression of the mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK in hepatocellular carcinoma: its role in tumor progression and apoptosis

H Huynh, TTT Nguyen, KHKP Chow, PH Tan… - BMC …, 2003 - Springer
Background Hepatocellular carcinoma (HCC) is one of the most common malignancies in
South East Asia. Although activation of the MEK-MAPK is often associated with cellular …

RAF-MEK-ERK pathway in cancer evolution and treatment

R Ullah, Q Yin, AH Snell, L Wan - Seminars in cancer biology, 2022 - Elsevier
Abstract The RAF-MEK-ERK signaling cascade is a well-characterized MAPK pathway
involved in cell proliferation and survival. The three-layered MAPK signaling cascade is …

Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer

PJ Roberts, CJ Der - Oncogene, 2007 - nature.com
Mitogen-activated protein kinase (MAPK) cascades are key signaling pathways involved in
the regulation of normal cell proliferation, survival and differentiation. Aberrant regulation of …